12/3
07:19 am
bhvn
Biohaven (NYSE:BHVN) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
Low
Report
Biohaven (NYSE:BHVN) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
11/29
02:38 pm
bhvn
Biohaven (BHVN): Assessing Valuation After Recent Share Price Boost [Yahoo! Finance]
Medium
Report
Biohaven (BHVN): Assessing Valuation After Recent Share Price Boost [Yahoo! Finance]
11/26
06:04 am
bhvn
Biohaven (NYSE:BHVN) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
Low
Report
Biohaven (NYSE:BHVN) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
11/25
01:48 pm
bhvn
Biohaven (NYSE:BHVN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Biohaven (NYSE:BHVN) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
01:57 pm
bhvn
Biohaven (NYSE:BHVN) had its price target lowered by analysts at JPMorgan Chase & Co. from $47.00 to $15.00. They now have an "overweight" rating on the stock.
Low
Report
Biohaven (NYSE:BHVN) had its price target lowered by analysts at JPMorgan Chase & Co. from $47.00 to $15.00. They now have an "overweight" rating on the stock.
11/18
01:34 pm
bhvn
Biohaven (NYSE:BHVN) had its price target lowered by analysts at Morgan Stanley from $54.00 to $26.00. They now have an "overweight" rating on the stock.
Low
Report
Biohaven (NYSE:BHVN) had its price target lowered by analysts at Morgan Stanley from $54.00 to $26.00. They now have an "overweight" rating on the stock.
11/16
10:26 pm
bhvn
William Blair Maintains Bullish Stance on Biohaven (BHVN), Sees Robust Operational Growth [Yahoo! Finance]
Low
Report
William Blair Maintains Bullish Stance on Biohaven (BHVN), Sees Robust Operational Growth [Yahoo! Finance]
11/15
07:05 pm
bhvn
Biohaven (BHVN): Assessing Valuation After $175 Million Stock Offering and FDA Setback [Yahoo! Finance]
Low
Report
Biohaven (BHVN): Assessing Valuation After $175 Million Stock Offering and FDA Setback [Yahoo! Finance]
11/13
06:52 pm
bhvn
Pfizer slashes stake in COVID vaccine partner BioNTech [Yahoo! Finance Canada]
Low
Report
Pfizer slashes stake in COVID vaccine partner BioNTech [Yahoo! Finance Canada]
11/13
03:18 pm
bhvn
Biohaven (NYSE:BHVN) had its price target lowered by analysts at Citigroup Inc. from $28.00 to $14.00. They now have a "buy" rating on the stock.
Neutral
Report
Biohaven (NYSE:BHVN) had its price target lowered by analysts at Citigroup Inc. from $28.00 to $14.00. They now have a "buy" rating on the stock.
11/12
03:58 pm
bhvn
Biohaven Q3 Earnings: Falling Back To Earth With A Thud [Seeking Alpha]
Low
Report
Biohaven Q3 Earnings: Falling Back To Earth With A Thud [Seeking Alpha]
11/12
07:35 am
bhvn
Biohaven Announces Pricing of $175 Million Public Offering of Common Shares [Yahoo! Finance]
Medium
Report
Biohaven Announces Pricing of $175 Million Public Offering of Common Shares [Yahoo! Finance]
11/12
07:23 am
bhvn
Biohaven announces pricing of $175M public offering of common shares [Seeking Alpha]
Medium
Report
Biohaven announces pricing of $175M public offering of common shares [Seeking Alpha]
11/12
07:15 am
bhvn
Biohaven Announces Pricing of $175 Million Public Offering of Common Shares
Low
Report
Biohaven Announces Pricing of $175 Million Public Offering of Common Shares
11/11
04:23 pm
bhvn
Biohaven launches $150 million proposed public offering [Seeking Alpha]
Low
Report
Biohaven launches $150 million proposed public offering [Seeking Alpha]
11/11
04:05 pm
bhvn
Biohaven Announces Proposed Public Offering of Common Shares
Medium
Report
Biohaven Announces Proposed Public Offering of Common Shares
11/11
07:03 am
bhvn
Biohaven (NYSE:BHVN) had its "market perform" rating reaffirmed by analysts at William Blair.
Medium
Report
Biohaven (NYSE:BHVN) had its "market perform" rating reaffirmed by analysts at William Blair.
11/10
07:10 am
bhvn
Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments [Yahoo! Finance]
Medium
Report
Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments [Yahoo! Finance]
11/10
07:03 am
bhvn
Biohaven GAAP EPS of -$1.64 beats by $0.29 [Seeking Alpha]
Medium
Report
Biohaven GAAP EPS of -$1.64 beats by $0.29 [Seeking Alpha]
11/10
06:58 am
bhvn
Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments
Medium
Report
Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments
11/10
01:51 am
bhvn
Why Biohaven (BHVN) Is Down 52.0% After FDA Setback Forces R&D Overhaul [Yahoo! Finance]
Medium
Report
Why Biohaven (BHVN) Is Down 52.0% After FDA Setback Forces R&D Overhaul [Yahoo! Finance]
11/6
10:50 am
bhvn
Biohaven (NYSE:BHVN) had its price target lowered by analysts at Royal Bank Of Canada from $19.00 to $9.00. They now have a "sector perform" rating on the stock.
Low
Report
Biohaven (NYSE:BHVN) had its price target lowered by analysts at Royal Bank Of Canada from $19.00 to $9.00. They now have a "sector perform" rating on the stock.
11/6
09:02 am
bhvn
Biohaven (NYSE:BHVN) was downgraded by analysts at Sanford C. Bernstein from an "outperform" rating to a "market perform" rating. They now have a $9.00 price target on the stock.
Low
Report
Biohaven (NYSE:BHVN) was downgraded by analysts at Sanford C. Bernstein from an "outperform" rating to a "market perform" rating. They now have a $9.00 price target on the stock.
11/6
08:10 am
bhvn
Biohaven (NYSE:BHVN) had its price target lowered by analysts at BTIG Research from $33.00 to $16.00. They now have a "buy" rating on the stock.
Low
Report
Biohaven (NYSE:BHVN) had its price target lowered by analysts at BTIG Research from $33.00 to $16.00. They now have a "buy" rating on the stock.
11/5
03:42 pm
bhvn
Biohaven (NYSE:BHVN) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating. They now have a $10.00 price target on the stock.
Medium
Report
Biohaven (NYSE:BHVN) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating. They now have a $10.00 price target on the stock.